Cargando…
The Epidermal Growth Factor Receptor (EGFR / HER-1) Gatekeeper Mutation T790M Is Present in European Patients with Early Breast Cancer
The epidermal growth factor receptor (EGFR) is one of the major oncogenes identified in a variety of human malignancies including breast cancer (BC). EGFR-mutations have been studied in lung cancer for some years and are established as important markers in guiding therapy with tyrosine kinase inhibi...
Autores principales: | Bemanian, Vahid, Sauer, Torill, Touma, Joel, Lindstedt, Bjørn Arne, Chen, Ying, Ødegård, Hilde Presterud, Vetvik, Katja Marjaana, Bukholm, Ida Rashida, Geisler, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534377/ https://www.ncbi.nlm.nih.gov/pubmed/26267891 http://dx.doi.org/10.1371/journal.pone.0134398 |
Ejemplares similares
-
In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics
por: McNamara, Keely M, et al.
Publicado: (2018) -
EGFR T790M: revealing the secrets of a gatekeeper
por: Ko, Brian, et al.
Publicado: (2017) -
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
por: Bahrami, Nazli, et al.
Publicado: (2021) -
Human Cytomegalovirus Protein Expression Is Correlated with Shorter Overall Survival in Breast Cancer Patients: A Cohort Study
por: Touma, Joel, et al.
Publicado: (2023) -
Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer
por: Daldorff, Stine, et al.
Publicado: (2017)